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ABSTRACT
Many studies have tried to identify specific nucleotide
sequences in the quasispecies of hepatitis C virus
(HCV) that determine resistance or sensitivity to inter-
feron (IFN) therapy, unfortunately without conclusive
results. Although viral proteins represent the most
evident phenotype of the virus, genomic RNA
sequences determine secondary and tertiary struc-
tures which are also part of the viral phenotype and
can be involved in important biological roles. In this
work, a method of RNA structure analysis has been
developed based on the hybridization of labelled HCV
transcripts to microarrays of complementary DNA
oligonucleotides. Hybridizations were carried out at
non-denaturing conditions, using appropriate tem-
perature and buffer composition to allow binding to
the immobilized probes of the RNA transcript without
disturbing its secondary/tertiary structural motifs.
Oligonucleotides printedonto themicroarraycovered
the entire 50 non-coding region (50NCR), the first three-
quarters of the core region, the E2–NS2 junction and
the first 400 nt of the NS3 region. We document the use
of this methodology to analyse the structural degree
of a large region of HCV genomic RNA in two geno-
types associated with different responses to IFN treat-
ment. The results reported here show different
structuraldegreealongthegenomeregionsanalysed,
and differential hybridization patterns for distinct
genotypes in NS2 and NS3 HCV regions.
INTRODUCTION
Hepatitis C virus (HCV) is one of the most important causes of
chronic liver disease worldwide and 3% of the population is
estimated to be infected (1). Molecular studies have shown
that the genome of HCV from a single isolate cannot be
defined by a single sequence but rather by a population of
variant sequences closely related to each other referred to as
viral quasispecies (2–5). This enormous diversity has gener-
ated genetically distinct groups or genotypes (6). It is well
known that HCV genotypes show different response to the
currently used antiviral treatment alpha-interferon (IFN-a)
in combination with ribavirin, which has a limited long-
term efficacy mostly in the HCV genotype 1b (7–9). Conse-
quently, a lot of effort has been put into trying to identify
specific sequences in the HCV viral quasispecies that may
determine resistance or sensitivity to antiviral therapy. Unfor-
tunately, results have been inconclusive (7–17) probably
because IFN-a does not specifically target a particular HCV
gene. IFN-a activity enhances host antiviral responses that, in
turn, exert selection pressures on various viral genome regions.
Thus, the targets of IFN-a action are likely to be numerous and
distributed over the entire genome (18–20).
Viral genomic RNA sequences determine secondary and
tertiary RNA structures which are part of the viral phenotype.
Distinct ordered structures in local regions of single-stranded
RNA sequences often correlate with functions such as control
of replication, transcription, mRNA processing and translation
(21,22). RNA structural motifs of viral genomes have been
shown to play important roles, acting as cis elements like the
internal ribosome entry sites (IRES) (23,24), internal hairpins
and pseudoknots directing expression of different open read-
ing frames in retroviruses (25–27), encapsidation signal in
human immunodeficiency virus (28–30) and tRNA-like ele-
ments described in plant viruses involved in viral replication
(31,32). Also, it has been recently demonstrated that the initia-
tion of HCV translation is directed by an RNA structural
element (33). Gene expression can also be modulated by
RNA structural elements in cellular mRNA in trans as in
the case of a pseudoknot in IFN-g mRNA that activates the
interferon-inducible protein kinase PKR (34). The RNA struc-
ture from the HCV 50 non-coding region (50NCR) (35–38) and
to a lesser extent those from the core region (39) and the
30NCR (40–42), have been the subject of many studies. How-
ever, the role of variant RNA structures present in the viral
quasispecies in relation with IFN sensitivity or resistance is
unknown.
In previous studies, structural features of HCV RNA of two
different genomic regions, 50NCR (43,44) and NS2 (45), have
been analysed using complementary deoxyoligonucleotide
probes and RNase H cleavage. Though this method has proven
to be a powerful tool to map RNA structural degree and to
determine accessible sites for ribozyme targeting, it is very
laborious and time consuming. In the present work, we have
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developed a methodology based on hybridizing labelled HCV
transcripts to arrays of complementary oligonucleotides, in
order to determine the structural degree of large regions in
the HCV RNA genome. The hypothesis was that by correlating
the intensity of hybridization signals with the degree of gen-
ome accessibility, it would be possible to distinguish regions
with relatively open RNA structures from those more tightly
folded. Here we document that DNA microarray technology
can be adapted to map structural degree of the HCV RNA
genome. This methodology offers the possibility to evaluate
the role of variability in HCV RNA, not at the sequence level
but at that of RNA structure, in patients infected with different
HCV genotypes and showing different responses to IFN
treatment.
MATERIALS AND METHODS
Oligonucleotide design
In a first approach, 20 DNA oligonucleotides were designed
for the construction of HCV-specific macroarrays: 6 of them
corresponded to the HCV 50NCR and 14 corresponded to the
NS2 coding region. These oligonucleotides were complemen-
tary to specific viral regions in which the genomic RNA adopts
different degrees of structure, as previously measured by
means of RNase H accessibility studies (44,45) (Figure 1A).
In a second step of the analysis, 156 DNA oligonucleotides
were designed for the construction of microarrays, correspond-
ing to the entire 50NCR (nt 1–361), the first three-quarters of
the core region (nt 342–751), the E2–NS2 junction (nt 2478–
3067) and the first 400 nt of the NS3 region (nt 3419–3819)
[numbered as HCV-1b, Gene Bank accession number S62220
(46), Figure 1B]. These oligonucleotides were complementary
to genomic regions from HCV-N (S62220) genotype 1b (46)
and HCV clone pJ6CF (AF177036) genotype 2a (47). Of them
74 were specific for genotype HCV-1b, 74 were specific for
genotype HCV-2a and 8 were common for both genotypes. All
the oligonucleotides were 20 nt long and their identification
number indicates the nucleotide number at the 50 position in
the original 1b sequence (the sequences of these oligonucleo-
tides are shown in the online supplementary data). They were
synthesized (TIB Molbiol) with an amino linker ‘C6’
[NH2(CH2)6] at their 5
0end, followed by a spacer of non-
specific (dT)15 track; purification was performed by high-
performance liquid chromatography (HPLC).
Spotting and attachment to glass slides
Oligonucleotides were diluted in spotting solution (Telechem-
Arrayit) and spotted onto super-epoxy-coated glass slides
(Telechem-Arrayit). Macroarrays were constructed by manu-
ally spotting 0.5 mL (dot diameter of approximately 1.5 mm,
Figure 2) of oligonucleotide solutions at concentrations of
Figure 1. Schematic representation of HCV genome indicating the number of oligonucleotides synthesized in the 50NCR and NS2 regions for macroarrays (A) and in
the 50NCR, core, NS2 and NS3 regions for microarrays (B).
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1, 10, 20 and 50 mM. Microarrays containing 156 oligonucleo-
tides were spotted by means of a GMS 417 arrayer
(Affymetrix), defining two contiguous subarrays or grids (geno-
type 1b at the left side and genotype 2a at the right side) and
printing these two-grid configuration twice on the same slide
(Figure 3). Each oligonucleotide, at 5 and 25 mM concentra-
tion, was spotted in triplicates as overlapping dots of 50 pl and
150 mm in diameter, with a centre-to-centre distance of 150 mm
(replicates) or 300 mm (different samples) (table B in the
supplementary data). Coupling was achieved 10 min after
printing. Printed macro and microarrays were kept, without
any further treatment, up to six months at room temperature.
Synthesis and labelling of in vitro transcripts
HCV RNA transcripts were derived from plasmid pN(1–4728)
that contains a fragment of HCV genotype 1b including
nucleotides 1 to 4728, and plasmid pJ6CF, which contains
the complete genome of HCV genotype 2a. Templates for
in vitro transcription were either linearized plasmids (digested
by Aat II or Bam HI for 50NCR or E2/NS2 junction region,
respectively) for the macroarrays, or PCR products obtained
from the same plasmids and containing a T7 RNA polymerase
promoter for the microarrays (Table 1). Standard 25 mL in vitro
transcription reactions were performed containing 1 mg DNA
template, 4 mL [a-33P]UTP (92 TBq/mmol; 2500 Ci/mmol),
400 mM each NTP and 1.6 U/mL T7 RNA polymerase
(Promega). After incubation for 2 h at 37C, the DNA template
was digested with 0.5 U DNase I (Promega) at 37C for 5 min.
Cellulose CF11 chromatography was used to eliminate DNA
fragments and non-incorporated nucleotides. When using lin-
earized plasmids, an extra purification step was performed in
order to eliminate incomplete or longer transcription products,
as described (48). The concentration of radioactive transcripts
was determined by calculating the amount of incorporated
[a-33P]UTP based on scintillation counting.
Hybridization and washing
Slides were processed just before hybridization to remove
unbound DNA molecules and printing buffer components
from the substrate. Briefly, the slides were washed for 2 min
at room temperature in 2· SSC, 0.1% sarcosyl, and for 2 min
at room temperature in 2· SSC. Oligonucleotides were
denatured for 2 min at 100C in H2O, cooled for 10 s at
Figure 2. Structural analysis of HCV RNA using macroarrays. Hybridization of HCV RNA transcripts from (A) 50NCR (402 nt long) and (B) NS2 region (562 nt long)
with oligonucleotides complementary to those regions printed as dots of 1.5 mm in diameter (0.5 ml) and concentrations ranging from 1 to 50 mM. (A) The
autoradiogram shows a strong hybridization signal in two accessible regions (C24 and C338). (B) The autoradiogram shows hybridization signals in oligonucleotides
corresponding to the most accessible regions of this genomic fragment (C2745, C2923, C2678, C2810).
Figure 3. Oligonucleotide arrangement on the microarrays. (A) A hundred and
fifty six oligonucleotides were spotted on the same slide in two contiguous
subarrays or grids: seventy-four oligonucleotides specific for genotype HCV-
1b and eight common for both genotypes were printed at the left side grid (1b),
and seventy-four specific for genotype HCV-2a were printed at the right side of
the slide (2a). This pattern has been printed twice on the microarray (B) As an
example, hybridization with RNA transcript HCV NS2-1b (plus 50NCR 1b for
location purposes) is shown. Cross hybridization of RNA transcript 1b with
genotype 2a-specific oligonucleotides, only occurs in oligo 338 (arrows)
sharing all the nucleotides but one between both genotypes.
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room temperature, fixed by plunging the slides for 2 min in ice
cold 100% ethanol and finally centrifuged for 1 min at 500 g.
Hybridization of the labelled transcripts was carried out
under non-denaturing conditions, using appropriate tempera-
ture and buffer composition to allow binding of the RNA
transcript to the immobilized probes, without disturbing its
secondary/tertiary structure (44). Hybridization mix consisted
of 60 nM labelled RNA transcript, 1· buffer H (20 mM
Hepes–HCl pH 7.8, 50 mM KCl, 10 mM MgCl2, 1 mM
DTT), 1· BSA, 50 mg/ml tRNA, 50 mg/ml poly A, 0.01%
SDS and 40 U RNasin. After 2 h of incubation in the hybri-
dization chamber (Genetix) at 37C, slides were washed for
15 min in 1· buffer H, 0.2% SDS and for 15 min in 1· buffer
H, at room temperature. The slides were finally dried by
spinning for 1 min at 500 g and immediately exposed either
to XAR-5 (Kodak) X-ray films (macroarrays), or to high reso-
lution BAS-SR (Fujifilm) imaging plates (microarrays).
Signals in the autoradiographs of the macroarrays were
compared by visual inspection. Hybridization signals in the
microarrays were captured by the Radioisotopic Image Ana-
lyser FLA-5000 (Fuji), with scanning pixels of 25 · 25 mm2.
Overlapping dots spotted onto the microarrays allowed hybri-
dization signals to be detected as ‘bands’ of about 150 ·
450 mm2. Analysis softwares FLA-Image Reader and Image
Gauge (Fuji) were used for reading and quantifying hybridiza-
tion images. Reproducibility of the method was assessed by
comparing the results of three different hybridization experi-
ments for each genotype and region. Error bars (mean and SD)
were calculated from the hybridization signals in each position
expressed as a percentage of the highest signal in the three
experiments (100% of hybridization).
RESULTS AND DISCUSSION
Duplex formation between complementary oligonucleotides
and long nucleic acids is not only determined by the sequence
complementarity and it is constrained by the secondary/
tertiary structure of the target nucleic acid. Experiments to
measure the effect of different single-stranded nucleic acid
structures, under high salt conditions, on the rate of duplex
formation on solid supports, have shown that RNA or cDNA
structural motifs may impede hybridization between probe and
target and, therefore, bias the results obtained in gene expres-
sion arrays (49–52). Here, we have reversed the argument and,
by taking advantage of the solid support hybridization tech-
niques, we have aimed at evaluating the structural degree of
long RNA molecules with potential application to HCV
diagnostics and therapeutics. We have first set up the condi-
tions for probing the accessibility of long HCV RNA tran-
scripts by hybridization to complementary oligonucleotides on
a solid support in macroarray format. In a second step, we have
constructed DNA microarrays to analyse the structural
degree of long HCV fragments in two different HCV
genotypes known to be associated to different responses to
IFN treatment.
A first approach on macroarrays
Macroarrays were constructed with a set of 20 DNA oligonu-
cleotides, corresponding to HCV regions previously known to
display different structural features: the 50NCR and the E2/
NS2 junction region. Macroarrays were hybridized with
labelled HCV RNA transcripts under non-denaturing condi-
tions. The autoradiogram in Figure 2A shows the hybridization
pattern of a 402 nt long HCV RNA transcript from the 50NCR.
Strong radioactive signal can be visualized in fully accessible
regions complementary to oligos C24 and C338, while the
other regions of limited or null accessibility cannot be discri-
minated showing weak or no radioactive signal. Figure 2B
shows the autoradiogram of the hybridization signal of a
562 nt long HCV RNA transcript from the E2/NS2 junction
region with complementary oligonucleotides. Radioactive sig-
nals were obtained in C2745, C2923, C2678 and C2810.
Images shown in Figure 2 have been reproducibly observed
in two independent experiments obtained by means of differ-
ent labelled RNA transcript preparations. These results are in
agreement with previous ones using RNase H and DNA
Table 1. Primers used for PCR amplifications of 50NCR, Core, NS2 and NS3 regions. (+) Sense primers, () antisense primers
Genotype Primer name Primer sequence (50-30) Amplified HCV region RNA transcript
length
HCV 1b 1b/2a 50T7 1(+) TAATACGACTCACTATAGGACCCGCCCCGATTGGGGGCGA 50NCR (1–360) 360 nt
1b 50 341 () GGTTTAGGATTCGTGCTCAT
1b/2a 50T7 1(+) TAATACGACTCACTATAGGACCCGCCCCGATTGGGGGCGA 50NCR (1–417) 417 nt
1b C393 () CCGGAATTCCCCGGGAACTTGACGTCCTGTGGGC
1b/2a CT7 358(+) TAATACGACTCACTATAGCCTCAAAGAAAAACCAA CORE (358–751) 393 nt
1b/2a 731 () GATACCCCATGAGGTCGGC
1b NS2T7 2487(+) TAATACGACTCACTATAGGGAGTATGTCGTGTTGCTT E2-NS2 junction (2487–3107) 620 nt
1b NS2 3087 () AGCGCGTACGAAGTACGGCA
1b NS3T7 3419(+) TAATACGACTCACTATAGGCGCCCATCACGGCCTAC NS3 (3419–3840) 421 nt
1b NS3 3820 () CCGAAGAGCCCTTCAAGTAG
1b/2a 50T7 1 (+) TAATACGACTCACTATAGGACCCGCCCCGATTGGGGGCGA 50NCR (1–362) 362 nt
2a 50 342 () GAGGTTTAGGATTTGTGCTC
1b/2a CT7 358 (+) TAATACGACTCACTATAGCCTCAAAGAAAAACCAA CORE (358–731) 393 nt
1b/2a C 731 () GATACCCCATGAGGTCGGC
HCV 2a 2a NS2T7 2499(+) TAATACGACTCACTATAGGGAGTGGGTAATACTCTTA E2-NS2 junction (2499–3118) 619 nt
2a NS2 3098 () AGCCCTGACGAAGTACGGCA
2a NS3T7 3430(+) TAATACGACTCACTATAGGCCCCCATCACTGCTTAC NS3 (3430–3851) 421 nt
2a NS3 3831 () CTGAGGACCCCTTCAAGGTG
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oligonucleotides in solution (43–45), and demonstrate the
suitability of the proposed method to distinguish highly struc-
tured RNA from less structured ones, in the HCV genome.
Macroarrays were printed manually and compared by visual
inspection and therefore not used for fine quantitation purposes
but they suggested that the approach was valid and we could
go to the next step using microarrays. In addition, in a control
experiment two non-accessible and one accessible sites
showed positive signals when the hybridization was performed
with labelled unstructured short 21mer RNA molecules (data
not shown).
Analysis of the structural profile along the HCV RNA
genome using microarrays
Genotype-specific microarrays for HCV 1b and HCV 2a were
prepared to cover the entire 50NCR, the first three-quarters of
the core region, the E2–NS2 junction region, and the first
400 nt of the NS3 region. Figure 4 shows the results of hybri-
dization of microarrays of genotype 1b and 2a with HCV RNA
transcripts corresponding to these regions. A high signal/back-
ground ratio was obtained, together with a remarkable speci-
ficity and reproducibility. Cross-hybridization between one
particular RNA transcript and non-specific oligonucleotides
on the same slide (i.e. RNA 1b transcript with oligonucleotides
genotype 2a specific, or vice versa) (see Figure 3) only occurs
when the oligonucleotides correspond to accessible regions
and differ in 1 or 2 nt between genotypes. This is the case
of oligonucleotides 338 in the 50NCR, and 361 and 381 in the
core region. In contrast, oligonucleotides differing in >3 nt
between genotype 1b and 2a showed absolute lack of cross-
hybridization, thus representing the negative controls of the
method. Inter-experiment reproducibility is represented by the
error bar graphs showed in Figure 5. They show the mean and
standard deviation (SD) of three different experiments for each
genotype and region. Hybridization patterns are coincident in
the different experiments, as it can be seen in Figure 4, where
one single and representative experiment is shown.
As a whole, microarray results confirmed the signals
obtained with macroarrays and demonstrated: (i) different
structural degree along the genome regions analysed and
(ii) different hybridization patterns for different genotypes
in certain HCV regions.
Genomic regions of conserved and structured RNA. The
50NCR and core regions (Figure 4A and B) show an important
degree of structural compactness that prevents hybridization
with most oligonucleotides: out of 34 oligonucleotides printed
(covering the first 750 nt of the HCV genome) only numbers
24, 338, 361 and 381 showed detectable hybridization signals
both for genotype 1b and 2a. Interestingly, when comparing
the hybridization of a 361 nt long HCV genotype 1b transcript
corresponding to the 50NCR and the first nucleotides of the
core region with the hybridization of a 417 nt long HCV
transcript from the same region (Figure 6), we observed
that the signal corresponding to oligo 338 was not detectable
in the hybridization of the longer fragment, and, instead, a
hybridization signal appeared in the last oligonucleotide cov-
ering this fragment (381). This suggests that hybridization
signals with oligonucleotides complementary to the end of
the transcript could be in some cases artefactual. Artificial
transcript ends could create exposed 50 and/or 30 terminal
sequences, otherwise compromised in secondary/
tertiary interactions in the full length RNA genome, as it
seems to be the case for oligonucleotides 338 and 361. It is
generally accepted that many secondary structures are local
and folding occurs as the RNA molecule is transcribed. This
makes some sequences to remain accessible to further long-
range interactions, while others show restricted accessibility to
distant regions. As elongation of the RNA chain proceeds,
more structures are added to the transcript which could
mask the accessible sites previously obtained (51). Therefore,
one should be cautious when interpreting accessible positions,
since long-range interactions may involve not only the ends of
an RNA transcript but also its internal regions, otherwise
revealed by the loss of hybridization signals that results
from extending the transcript length. In contrast, we can
be very confident of our results when considering secondary
local elements or short-range interactions demonstrated by
a reduction or a total lack of heteroduplex formation in
microarrays.
Our results also point out that, except for the position cor-
responding to oligo 24 (nt 24–44), the structural degree of the
50NCR and core represents, as a whole, a non-accessible
region to probe hybridization. Biochemical and functional
studies have established that the HCV 50NCR folds into a
highly ordered complex structure with multiple stem–loops
(35,37,53,54). These regions contains two distinct RNA ele-
ments: a short 50 proximal RNA element (nt 1–43) that regu-
lates HCV RNA replication and a longer IRES element
(nt 44–370) where protein synthesis starts, eventually leading
to production of the polyprotein precursor. The results
reported here, both with the 361 nt long and the 417 nt
long HCV transcripts (Figure 6), fit quite well with the
model proposed for a compact IRES element and an accessible
region corresponding to the 50 proximal RNA element, mainly
to nucleotides 24–44 (35,37,53,54).
It is interesting to note that hybridization on solid support is
a more restrictive method than mapping the structural degree
by RNase H and complementary DNA oligonucleotides in
solution. Using our conditions, a relatively reduced signal
in the solid support with regard to the experiment in solution
would be attributable either to stearic constrains of the folded
RNA target to approximate the oligonucleotide or to unspe-
cific interactions of the RNA with the chemically modified
solid support. The first hypothesis might be the most appro-
priate for the case of the 50 untranslated region of HCV RNA
which is an exceptionally highly structured domain and might
approach the solid support in a preferred orientation. As an
example,RNaseHstimulatesmoderatecleavage inposition 255
(44) while it seems non-accessible in the microarray experi-
ment. Also, stem–loop IIIb, which is accessible to single-
stranded-specific nucleases and expected to be an accessible
region, is not observed in our hybridization on solid support.
Apart from its 50 end, the lack of accessibility in the entire
analysed fragment of the core-encoding region (nt 342–751)
was very surprising and suggests a compact folding not
expected for a region only involved in protein coding. The
earliest evidence that the HCV core RNA sequence harbours
additional functions than coding for a single protein was the
observation that the rate of synonymous substitution for the
core gene was remarkably lower than that for the other HCV
genes (55,56). The limitation in the number of synonymous
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substitutions in this region has been explained by the possi-
bility of encoding an alternative protein by frame shifting
(ARFP) (57,58), and by the existence of internally base-paired
stem–loop structures in this region (39). Our results suggest
that at least the first three-quarters of the core region contain a
number of RNA structural elements that probably lead to
structural constraints to nucleotide replacements in this region.
Genomic regions of accessible and variable RNA. A very
different situation is observed in the 620 nt long fragment
from the E2/NS2 junction region (Figure 4C) and in the
420 nt long fragment from the NS3 region (Figure 4D).
Both RNA transcripts show complex hybridization patterns
that indicate much less structured regions, where accessible
positions alternate with more compact fragments. The hybri-
dization patterns clearly differ between genotype 1b and 2a in
both regions. The quantitation results show that in the E2/NS2
junction region (Figure 4C) the fragment corresponding
to oligonucleotides 2829–2862 is not accessible at all in
genotype 1b, but it is highly accessible in genotype 2a.
The opposite situation is found for fragment 2724–2767,
where genotype 1b is more accessible than genotype 2a.
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Other regions, as 2487–2507, 2547–2567 and 2987–3067 are
relatively accessible in both genotypes. Interestingly,
the presence of a tRNA-like structure, flanking position
2860–2861 in the genome of HCV genotype 1b has
been recently demonstrated (48). Also, this structure was con-
sistently maintained in several HCV-1b variants, although
they differ in the primary sequence at or near the relevant
domain. Our results are consistent with the presence of an
Figure 4. Analysis of the RNA structural degree in different regions of HCV-1b and HCV-2a genomes using DNA microarrays. The oligonucleotides were printed as
overlapping triplicate spots of 150 mm in diameter, at two concentrations (5 and 25 mM). The relative positions of the spotted oligonucleotides is different for
genotypes 1b and 2a (see details in Table B in the supplementary data). The HCV genome regions analysed were the entire 50NCR (A), the first three quarters of core
region (B), the E2/NS2 junction region (C) and the first 400 nt of NS3 region (D). Hybridization signals of RNA transcripts corresponding to HCV genotypes 1b and
2a are shown at the left. 50NCR-1b RNA transcript was added to the hybridization mix when analysing NS2 and NS3 regions, as positive control in the printed area.
Quantitation of hybridization signals is shown at the right part of each panel. (PB)/mm2 indicates the area density of photo-stimulated luminescence (PSL) of
hybridization signal minus background. White bars correspond to the quantitation of hybridization signals with oligonucleotides printed at 5 mM concentration; the
sum of white and black bars correspond to the quantitation of hybridization signals with oligos printed at 25 mM.
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important RNA structural element involving nucleotides
2829–2862 in the RNA transcript corresponding to genotype
1b, while the same fragment seems to be accessible in geno-
type 2a.
In the NS3 region (Figure 4D), genotype 1b is, in general,
much more accessible than genotype 2a, particularly in the
fragment corresponding to oligonucleotides 3619–3799.
Perspectives of the DNA microarrays methodology
in the study of HCV genome
A specific sequence intrinsically involved in resistance to IFN
treatment, i.e. significantly correlated with non-responder
patients, has not been described. Nevertheless, an inverse cor-
relation has been demonstrated between quasispecies complex-
ity in different genomic regions and response to IFN treatment
(12,59–61).Approaching theextremelyhighsequencevariation
of HCV by analysing the limited variability of its RNA struc-
tures can simplify the study of quasispecies in relation to IFN
resistance or sensitivity in patients infected with different HCV
genotypes. Theoretical studies suggest that quasispecies
sequence space is much more complex than the corresponding
space of variant structures: several variant sequences can adopt
the same RNA secondary structure (62) and, additionally, func-
tional secondary/tertiary structures are strongly conserved.
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The antiviral activity of IFN involves induction of transcrip-
tion of several antiviral genes, such as the double-stranded (ds)
RNA-dependent protein kinase, which is activated in the
presence of dsRNA. In this activated form, PKR inhibits
the synthesis of (cellular or viral) proteins (63). It has been
recently shown that a region of the viral RNA comprising part
of the IRES is able to bind to PKR in competition with dsRNA,
preventing activation of kinase in vitro and diminishing its
Figure 5. Reproducibility analysis. The results of three different hybridization experiments for each genotype and region were compared. Error bars (mean and SD)
were calculated from the hybridization signals in each position expressed as a percentage of the highest signal in the three experiments (100% of hybridization),
identified with an asterisk.
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inhibitory effect (64). However, the HCV IRES, comprising
the 50NCR and the first nucleotides of the HCV coding
sequence is highly conserved between isolates. In particular,
the nucleotide variations found have little effect on the
extensive secondary structure of the IRES, consistently with
our results in 50NCR and core region in two different geno-
types. Although current evidences cannot exclude it com-
pletely, it seems unlikely that the structural elements present in
the HCV IRES could account for the differences in sensitivity
or resistance to IFN treatment associated with HCV genotypes.
The results reported here also show a differential structural
degree in the internal genomic regions NS2 and NS3 in HCV
genotypes 1b and 2a, although, we cannot presume any impli-
cation of these structural differences in the modulation of the
inhibitory effect of IFN on the synthesis of viral proteins.
In conclusion, we have documented that DNA microarray
technology can be used as a high-throughput method to ana-
lyse the entire HCV genome for the identification of RNA
structural elements. The next step would be to use this tech-
nology to analyse complete HCV genomes obtained from
infected patients showing different response pattern to anti-
viral treatment. Classification of hybridization profiles and
correlation to IFN resistance or sensitivity could help to iden-
tify the genetic determinants of this complex phenomenon.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at NAR Online: Table A,
list of oligonucleotides printed on the microarrays; Table B,
location and concentrations of oligonucleotides printed on the
microarrays.
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